Media Advisory - New Study Shows Reduction in Anti-Depressant Withdrawal Symptoms



    Canadian Pharmacists' Invention Offers Relief for Thousands Battling
    Depression

    MONTREAL, Nov. 15 /CNW/ -

    
    Who:      Mr. Scott Leslie, President, Pharmacy.ca, Dr. Willem Wassenaar,
              Medical Director, Pharmacy.ca. and Mr. Dipen Kalaria, Director
              of Specialty Pharmacy Services, Pharmacy.ca

    What:     A presentation to the Canadian Psychiatric Association Annual
              Meeting of the first study to show that the 10-step (10-week)
              medication tapering process invented by Canadian pharmacists at
              Pharmacy.ca reduces the severity and frequency of withdrawal
              side effects with the most commonly used anti-depressants. The
              strength of the medication in the study was gradually reduced
              using a new point-of-sale encapsulation system that can make
              most medications in any strength.

    Where:    Canadian Psychiatric Association Annual Meeting
              Fairmont Queen Elizabeth Hotel (Hochelaga Room 1)
              900 Rene Levesque Blvd. West
              Montreal, Quebec

    When:     Friday, November 16, 2007
              6:00 p.m. - 7:30 p.m.

    Why:      15.5-million prescriptions for antidepressants are written in
              Canada each year. Thirty per cent of patients who have
              recovered from a bout of depression and now want to discontinue
              their medication will suffer from SSRI discontinuation syndrome
              (i.e., withdrawal symptoms) including dizziness, confusion,
              headaches, nervousness, nausea, irritability and crying.
              Product monographs in the Compendium of Pharmaceuticals and
              Specialties for commonly prescribed SSRI antidepressants all
              carry warnings and recommend dose titration to avoid
              discontinuation syndrome. Unfortunately medications normally
              come in one or two strengths and the monographs do not provide
              guidance about how to slowly reduce the strength of the
              medications.

                 Pre-Event Photo and Interview Opportunities
    




For further information:

For further information: Kevin Putnam, Expresso - (416) 537-1128 or
(416) 417-1893

Organization Profile

PHARMACY.CA

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890